Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens
Peter Larsson(Sahlgrenska University Hospital), Toshima Z. Parris(Sahlgrenska University Hospital)
Cited by 220
Related Papers
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma
|International Journal of Cancer|2013|69